Harvard Management Company’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.97M | Hold |
170,000
| – | – | 0.14% | 14 |
|
|
2025
Q1 | $1.48M | Hold |
170,000
| – | – | 0.13% | 13 |
|
|
2024
Q4 | $2.44M | Hold |
170,000
| – | – | 0.14% | 16 |
|
|
2024
Q3 | $3.84M | Hold |
170,000
| – | – | 0.22% | 13 |
|
|
2024
Q2 | $3.31M | Hold |
170,000
| – | – | 0.2% | 13 |
|
|
2024
Q1 | $6.38M | Hold |
170,000
| – | – | 0.4% | 10 |
|
|
2023
Q4 | $9.51M | Hold |
170,000
| – | – | 0.8% | 10 |
|
|
2023
Q3 | $7.01M | Sell |
170,000
-16,143
| -9% | -$666K | 0.79% | 12 |
|
|
2023
Q2 | $10.4M | Hold |
186,143
| – | – | 1.02% | 10 |
|
|
2023
Q1 | $10.4M | Hold |
186,143
| – | – | 1.09% | 13 |
|
|
2022
Q4 | $6.78M | Hold |
186,143
| – | – | 0.84% | 21 |
|
|
2022
Q3 | $5.3M | Hold |
186,143
| – | – | 0.66% | 24 |
|
|
2022
Q2 | $8.42M | Hold |
186,143
| – | – | 0.98% | 17 |
|
|
2022
Q1 | $14.2M | Hold |
186,143
| – | – | 1.43% | 9 |
|
|
2021
Q4 | $27.7M | Hold |
186,143
| – | – | 2.6% | 7 |
|
|
2021
Q3 | $27.1M | Hold |
186,143
| – | – | 1.59% | 11 |
|
|
2021
Q2 | $36.5M | Buy |
186,143
+96,667
| +108% | +$18.9M | 2.1% | 10 |
|
|
2021
Q1 | $16.2M | Buy |
+89,476
| New | +$16.2M | 0.9% | 18 |
|